Financials OmniAb, Inc.

Equities

OABI

US68218J1034

Biotechnology & Medical Research

Market Closed - Nasdaq 04:00:03 2024-05-31 pm EDT 5-day change 1st Jan Change
4.35 USD -2.90% Intraday chart for OmniAb, Inc. -0.91% -29.50%

Valuation

Fiscal Period: December 2022 2023 2024 2025 2026
Capitalization 1 413.4 717.6 510.5 - -
Enterprise Value (EV) 1 325.1 717.6 510.5 510.5 510.5
P/E ratio -13.8 x -12.1 x -6.86 x -10.2 x -15.1 x
Yield - - - - -
Capitalization / Revenue 7 x 21 x 17.4 x 9.18 x 6.73 x
EV / Revenue 7 x 21 x 17.4 x 9.18 x 6.73 x
EV / EBITDA -30.4 x -12.8 x -8.81 x -14.6 x -50 x
EV / FCF -19.9 x -17.7 x -11.2 x -14.1 x 156 x
FCF Yield -5.02% -5.64% -8.91% -7.08% 0.64%
Price to Book 1.22 x - - - -
Nbr of stocks (in thousands) 114,821 116,301 117,615 - -
Reference price 2 3.600 6.170 4.340 4.340 4.340
Announcement Date 3/30/23 3/20/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2022 2023 2024 2025 2026
Net sales 1 59.08 34.16 29.36 55.61 75.85
EBITDA 1 -13.6 -55.86 -57.94 -34.89 -10.2
EBIT 1 -26.65 -69.42 -79.56 -51.76 -32.08
Operating Margin -45.11% -203.19% -270.99% -93.06% -42.3%
Earnings before Tax (EBT) 1 -26.06 -64.36 -75.89 -49.02 -34.11
Net income 1 -22.33 -50.62 -66.48 -46.24 -31.26
Net margin -37.8% -148.16% -226.44% -83.14% -41.21%
EPS 2 -0.2600 -0.5100 -0.6325 -0.4271 -0.2875
Free Cash Flow 1 -20.76 -40.44 -45.48 -36.12 3.263
FCF margin -35.13% -118.37% -154.9% -64.95% 4.3%
FCF Conversion (EBITDA) - - - - -
FCF Conversion (Net income) - - - - -
Dividend per Share - - - - -
Announcement Date 3/30/23 3/20/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 6.91 35.34 16.92 6.946 5.477 4.822 3.801 6.078 8.249 11.21 7.628 8.126
EBITDA 1 - - -5.084 -16.06 -16.92 -17.8 -17.6 -16.37 -13.99 -9.976 -17.41 -16.96
EBIT 1 - 9.05 -8.453 -19.44 -20.32 -21.21 -22.55 -21.55 -19.81 -17.56 -22.36 -21.91
Operating Margin - 25.6% -49.96% -279.95% -370.91% -439.78% -593.34% -354.55% -240.13% -156.65% -293.09% -269.62%
Earnings before Tax (EBT) 1 - 9.637 -7.129 -18.16 -19.04 -20.03 -21.58 -20.01 -18.27 -15.94 - -
Net income 1 -12.6 6.82 -6.1 -14.73 -15.74 -14.05 -18.96 -17.83 -16.08 -13.61 -15.44 -15.16
Net margin -182.29% 19.3% -36.05% -212.04% -287.35% -291.44% -498.84% -293.44% -194.97% -121.35% -202.4% -186.59%
EPS 2 - 0.0700 -0.0600 -0.1500 -0.1600 -0.1400 -0.1900 -0.1688 -0.1500 -0.1262 -0.1600 -0.1600
Dividend per Share - - - - - - - - - - - -
Announcement Date 11/14/22 3/30/23 5/11/23 8/10/23 11/9/23 3/20/24 5/9/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2022 2023 2024 2025 2026
Net Debt - - - - -
Net Cash position 88.3 - - - -
Leverage (Debt/EBITDA) - - - - -
Free Cash Flow 1 -20.8 -40.4 -45.5 -36.1 3.26
ROE (net income / shareholders' equity) -7.76% - - - -
ROA (Net income/ Total Assets) - - - - -
Assets 1 - - - - -
Book Value Per Share 2.960 - - - -
Cash Flow per Share 2 -0.0400 -0.2300 -0.3100 - -
Capex 1 17.2 1.64 5 5 5.25
Capex / Sales 29.06% 4.81% 17.03% 8.99% 6.92%
Announcement Date 3/30/23 3/20/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
4.34 USD
Average target price
9.875 USD
Spread / Average Target
+127.53%
Consensus
  1. Stock Market
  2. Equities
  3. OABI Stock
  4. Financials OmniAb, Inc.